炎症 IKKβ- XBP1sの相互作用により,グルコースホメオスタシスを改善する
Junli Liu1, Dorina Ibi1, Koji Taniguchi2
1Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02130, USA.
Cell
|November 5, 2016
まとめ
IκBキナーゼβ (IKKβ) が関わる炎症は,肝臓のグルコースバランスを正常に調節する. 肥満マウスにおけるIKKβの増強は,ERのストレスを軽減することによって,インスリン感受性とグルコースホメオスタシスを改善した.
科学分野:
- 代謝と内分泌学
- 分子生物学
- セルラー・シグナル
背景:
- 肥満に関連する炎症は2型糖尿病の発症と関連しています.
- IκBキナーゼβ (IKKβ) は炎症経路における重要なキナーゼであり,しばしばインスリン抵抗性に関与する.
- 肝臓のグルコース代謝におけるIKKβ媒介の炎症の正確な役割は完全に理解されていません.
研究 の 目的:
- 肝臓のグルコースホメオスタシスにおけるIKKβ媒介の炎症の役割を調査する.
- 肥満におけるIKKβ活性調節がインスリン感受性およびグルコース調節に影響するかどうかを判断する.
主な方法:
- 肥満マウスの肝臓で特にIKKβ活動を高めるために,3つの異なる実験戦略を使用した.
- 強化されたIKKβ活性がX-Box結合タンパク質1 (XBP1s) のスプライシング活性に与える影響を評価した.
- エンドプラズマ網膜 (ER) のストレスレベルをモニタリングし,インスリン感受性とグルコースホメオスタシスを評価した.
主要な成果:
- IKKβの活性が増加すると,肝臓におけるXBP1sの活性が増加した.
- IKKβの活性が上昇した結果,ERのストレスが減少した.
- 肝臓のIKKβ活性が増加した肥満マウスは,インスリン感受性とグルコースホメオスタシスの有意な改善を示した.
結論:
- 一般的な考えとは対照的に,IKKβ媒介の肝炎は,グルコースホメオスタシスのポジティブレギュレーターとして作用する.
- XBP1sのIKKβリン酸化は,これらの有益な効果を誘発する重要なメカニズムです.
- 肝臓のIKKβ活性をターゲットにすることで,インスリン抵抗性および2型糖尿病の管理のための新しい治療戦略を提供することができる.
関連する概念動画
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.9K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.9K
Hormones Regulating Blood Glucose
8.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
8.0K
Glucose Homeostasis: Regulation of Blood Glucose
4.9K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.9K
Insulin Secretory Vesicles
7.2K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.2K
Cell Specific Gene Expression
16.8K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.8K
Dipeptidyl Peptidase 4 Inhibitors
845
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
845


